切换至 "中华医学电子期刊资源库"

中华介入放射学电子杂志 ›› 2019, Vol. 07 ›› Issue (04) : 273 -277. doi: 10.3877/cma.j.issn.2095-5782.2019.04.002

所属专题: 文献

肿瘤介入

超声引导下经皮微波消融治疗肝癌胸腹壁种植转移
安超1, 于杰1, 于晓玲1, 程志刚1, 韩治宇1, 刘方义1, 梁萍1,()   
  1. 1. 100853 北京,中国人民解放军总医院介入超声科
  • 收稿日期:2019-09-13 出版日期:2019-11-01
  • 通信作者: 梁萍
  • 基金资助:
    国家自然科学基金(81871734、81627803、91859201)

Ultrasound-guided percutaneous microwave ablation of seeding from hepatocellular carcinoma in thoracoabdominal wall

Chao An1, Jie Yu1, Xiaoling Yu1, Zhigang Cheng1, Zhiyu Han1, Fangyi Liu1, Ping Liang1,()   

  1. 1. Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing 100853, China
  • Received:2019-09-13 Published:2019-11-01
  • Corresponding author: Ping Liang
  • About author:
    Corresponding author: Liang Ping, Email:
引用本文:

安超, 于杰, 于晓玲, 程志刚, 韩治宇, 刘方义, 梁萍. 超声引导下经皮微波消融治疗肝癌胸腹壁种植转移[J]. 中华介入放射学电子杂志, 2019, 07(04): 273-277.

Chao An, Jie Yu, Xiaoling Yu, Zhigang Cheng, Zhiyu Han, Fangyi Liu, Ping Liang. Ultrasound-guided percutaneous microwave ablation of seeding from hepatocellular carcinoma in thoracoabdominal wall[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2019, 07(04): 273-277.

目的:

探讨超声引导下经皮微波消融治疗肝癌胸腹壁种植转移的有效性和可行性。

方法:

选取2007年1月至2017年1月在中国人民解放军总医院出现肝癌胸腹壁种植转移后接受超声引导下经皮微波消融治疗的患者15例,男13例,女2例,平均年龄(57.2±17.6岁)。收集种植转移的人口和肿瘤特征,分析患者治疗情况,采用Log-Rank χ2检验统计分析种植灶消融后的局部进展率及患者的总生存率,采用多因素Cox回归分析肝癌胸腹壁种植转移患者总体生存情况的危险因素。

结果:

15例患者的中位随访27.8(3.8~67.2)个月,消融治疗后种植肿瘤患者的0.5、1、2年的累积局部进展率分别为6.7%、23.0%、23.0%;1、3、5年的累积总生存率分别为80.0%、61.7%、46.3%。多因素Cox回归分析显示年龄>65岁、肝内病灶控制差及肿瘤分型差是影响肝癌胸腹壁种植转移患者总体生存情况的危险因素。

结论:

超声引导下经皮微波消融治疗肝癌胸腹壁种植转移能够产生令患者满意的肿瘤结局,但延长患者生存时间还主要依靠对肝内病灶的控制。

Objective:

The objective of the study is to evaluate the effectiveness and feasibility of ultrasound-guided percutaneous microwave ablation (MWA) in patients who occurred seeding from hepatocellular carcinoma (HCC) in thoracoabdominal wall.

Methods:

A total of 15 patients (13 men, 2 women; 57.2±17.6 years) with the seeding from HCC in thoracoabdominal wall, underwent US-guided percutaneous MWA and were included in the study from January 2007 to January 2017. We collect the population and tumor characteristics of the seeding. Local seeding progression (LSP) and overall survival (OS) are analyzed statistically with the log-rank test. Multivariate analysis are performed on clinico-pathological variables to identify factors affecting OS.

Results:

After a median follow-up time of 27.8 (3.8-67.2) months, cumulative 0.5-, 1-, 2-years LSP rate is 6.7%, 23.0% and 23.0%, respectively. And cumulative 1-, 3-, 5-years OS rate is 80.0%, 61.7%, and 46.3%, respectively. Multivariate analysis show that older age (P=0.006, HR=2.218, 95%CI=1.338-4.923) , poor control of intrahepatic lesion (P=0.002, HR=5.529, 95%CI=2.372-15.443) and poor pathological type (P=0.021, HR=2.782, 95%CI=1.035-4.112) are independently associated with OS.

Conclusions:

Ultrasound-guided percutaneous microwave ablation in the treatment of seeding from HCC in thoracoabdominal wall, which can produce satisfactory tumor outcomes, but the survival of patients depends mainly on the control of intrahepatic lesions.

表1 15例肝癌种植转移患者的基线特征
图1 不肝细胞癌种植转移典型病例(男性,65岁,增强MRI示肝脏S4段1.4 cm×1.3 cm×1.0 cm结节)行超声引导下经皮微波消融治疗前后
图2 肝癌腹壁种植转移典型病例(男性,54岁)行超声引导下经皮微波消融治疗前后
图3 肝癌胸腹壁种植转移患者的局部进展率和总生存率
表2 多因素Cox回归分析肝癌患者胸腹壁种植转移的影响因素
[1]
Aldahham A, Boodai S, Alfuderi A,et al. Abdominal wall implantation of hepatocellular carcinoma[J]. World J Surg Oncol,2006,4: 72.
[2]
Brodsky JT, Cohen AM. Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy[J]. Dis Colon Rectum,1991,34(8): 723-727.
[3]
De Cobelli F, Marra P, Ratti F,et al. Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions: New advances in interventional oncology: state of the art[J]. Med Oncol,2017,34(4): 49.
[4]
Ahmed M, Technology Assessment Committee of the Society of Interventional Radiology. Image-guided tumor ablation: standardization of terminology and reporting criteria: a 10-year update: supplement to the consensus document[J]. J Vasc Interv Radiol,2014,25(11): 1706-1708.
[5]
Fung E, Strosberg DS, Jones EL,et al. Incidence of abdominal wall metastases following percutaneous endoscopic gastrostomy placement in patients with head and neck cancer[J]. Surg Endosc,2017,31(9): 3623-3627.
[6]
Sawant A, Bansal S, Pawar P,et al. Early metastasis to anterior abdominal wall following radical cystectomy: A rare presentation[J]. Urol Ann,2016,8(3): 394-396.
[7]
Shirai K, Tamai H, Shingaki N,et al. Clinical features and risk factors of extrahepatic seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma[J]. Hepatol Res,2011,41(8): 738-745.
[8]
Liang P, Wang Y, Yu XL,et al. Malignant liver tumors: treatment with percutaneous microwave ablation: complications among cohort of 1136 patients[J]. Radiology,2009,251(3): 933-940.
[9]
Wang CP, Wang H, Qu JH,et al. Tumour seeding after percutaneous cryoablation for hepatocellular carcinoma[J]. World J Gastroenterol,2012,18(45): 6587-6596.
[10]
Takemura N, Hasegawa K, Aoki T,et al. Surgical resection of peritoneal or thoracoabdominal wall implants from hepatocellular carcinoma[J]. Br J Surg,2014,101(8): 1017-1022.
[11]
于杰,梁萍,于晓玲,等.超声引导下经皮水冷微波和水冷射频消融治疗早期肝细胞癌的实验研究及临床随机对照研究[C]//中国超声医学工程学会第一届全国介入超声及肿瘤消融学术会议论文集.北京,2011: 76.
[12]
Yu J, Liang P. Status and advancement of microwave ablation in China[J]. Int J Hyperthermia,2017,33(3): 278-287.
[13]
Yu J, Liang P, Yu XL,et al. Local tumour progression after ultrasound-guided microwave ablation of liver malignancies: risk factors analysis of 2529 tumours[J]. Eur Radiol,2015,25(4): 1119-1126.
[14]
Zhang XG, Zhang ZL, Hu SY,et al. Ultrasound-guided ablative therapy for hepatic malignancies: a comparison of the therapeutic effects of microwave and radiofrequency ablation[J]. Acta Chir Belg,2014,114(1): 40-45.
[15]
Wang QC, Cheng W, Zhang L,et al. Use of percutaneous sonographically guided microwave ablation therapy to treat inoperable malignant liver tumours[J]. West Indian Med J,2015,64(2): 76-80.
[1] 张婉微, 秦芸芸, 蔡绮哲, 林明明, 田润雨, 金姗, 吕秀章. 心肌收缩早期延长对非ST段抬高型急性冠脉综合征患者冠状动脉严重狭窄的预测价值[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1016-1022.
[2] 任书堂, 刘晓程, 张亚东, 孙佳英, 陈萍, 周建华, 龙进, 黄云洲. 左心室辅助装置支持下单纯收缩期主动脉瓣反流的超声心动图特征[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1023-1028.
[3] 何金梅, 尹立雪, 谭静, 张文军, 王锐, 任梅, 廖明娇. 超声心肌做功技术对2型糖尿病患者潜在左心室心肌收缩功能损伤的评价[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1029-1035.
[4] 薛艳玲, 马小静, 谢姝瑞, 何俊, 夏娟, 何亚峰. 左心声学造影在急性心肌梗死合并室间隔穿孔中的应用价值[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1036-1039.
[5] 吕琦, 惠品晶, 丁亚芳, 颜燕红. 颈动脉斑块易损性的超声造影评估及与缺血性卒中的相关性研究[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1040-1045.
[6] 魏淑婕, 惠品晶, 丁亚芳, 张白, 颜燕红, 周鹏, 黄亚波. 单侧颈内动脉闭塞患者行颞浅动脉-大脑中动脉搭桥术的脑血流动力学评估[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1046-1055.
[7] 武玺宁, 欧阳云淑, 张一休, 孟华, 徐钟慧, 张培培, 吕珂. 胎儿心脏超声检查在抗SSA/Ro-SSB/La抗体阳性妊娠管理中的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1056-1060.
[8] 杨水华, 何桂丹, 覃桂灿, 梁蒙凤, 罗艳合, 李雪芹, 唐娟松. 胎儿孤立性完全型肺静脉异位引流的超声心动图特征及高分辨率血流联合时间-空间相关成像的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1061-1067.
[9] 张璇, 马宇童, 苗玉倩, 张云, 吴士文, 党晓楚, 陈颖颖, 钟兆明, 王雪娟, 胡淼, 孙岩峰, 马秀珠, 吕发勤, 寇海燕. 超声对Duchenne肌营养不良儿童膈肌功能的评价[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1068-1073.
[10] 张宝富, 俞劲, 叶菁菁, 俞建根, 马晓辉, 刘喜旺. 先天性原发隔异位型肺静脉异位引流的超声心动图诊断[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1074-1080.
[11] 丁雷, 罗文, 杨晓, 庞丽娜, 张佩蒂, 刘海静, 袁佳妮, 刘瑾. 高帧频超声造影在评价C-TIRADS 4-5类甲状腺结节成像特征中的应用[J]. 中华医学超声杂志(电子版), 2023, 20(09): 887-894.
[12] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[13] 冯冰, 邹秋果, 梁振波, 卢艳明, 曾奕, 吴淑苗. 老年非特殊型浸润性乳腺癌超声征象与分子生物学指标的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 48-51.
[14] 赵文毅, 邹冰子, 蔡冠晖, 刘永志, 温红. 超声应变力弹性成像联合MRI-DWI靶向引导穿刺在前列腺病变诊断中的应用[J]. 中华临床医师杂志(电子版), 2023, 17(9): 988-994.
[15] 薛念余, 张盛敏, 吴凌恒, 沙蕾, 童揽月, 沈崔琴, 李朝军, 杜联芳. 研究血清胆红素对2型糖尿病患者心脏结构发生改变前心肌功能的影响[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1004-1009.
阅读次数
全文


摘要